MINI REVIEW
Published on 27 Dec 2024
Nanobodies: A Promising Strategy for Asthma Therapy
doi 10.3389/fphar.2024.1510806
- Frontiers in Pharmacology
- Respiratory Pharmacology
- Research Topics
- Therapeutic Advances in Lung Cancer and Chronic Inflammatory Lung Disease
Therapeutic Advances in Lung Cancer and Chronic Inflammatory Lung Disease
4,734
Total downloads
16k
Total views and downloads
Submit your idea
Select the journal/section where you want your idea to be submitted:
Articles
CASE REPORT
Published on 24 Dec 2024
Recurrent pneumothoraces caused by a high-grade lung carcinoma with trophoblastic differentiation: a case report
doi 10.3389/fonc.2024.1462865
- 127 views
ORIGINAL RESEARCH
Published on 16 Dec 2024
Uvaol attenuates TGF-β1-induced epithelial-mesenchymal transition in human alveolar epithelial cells by modulating expression and membrane localization of β-catenin
doi 10.3389/fphar.2024.1504556
ORIGINAL RESEARCH
Published on 16 Dec 2024
CD146 promotes resistance of NSCLC brain metastases to pemetrexed via the NF-κB signaling pathway
doi 10.3389/fphar.2024.1502165
REVIEW
Published on 11 Dec 2024
Mitochondrial quality control: a pathophysiological mechanism and potential therapeutic target for chronic obstructive pulmonary disease
doi 10.3389/fphar.2024.1474310
CASE REPORT
Published on 22 Nov 2024
Rare cancer with primary pleural epithelioid hemangioendothelioma diagnosed by thoracoscopic biopsy achieving disease control after 16 months: case report and literature review
doi 10.3389/fphar.2024.1482154
- 216 views
REVIEW
Published on 18 Oct 2024
Attenuating mitochondrial dysfunction-derived reactive oxygen species and reducing inflammation: the potential of Daphnetin in the viral pneumonia crisis
doi 10.3389/fphar.2024.1477680
- 514 views
REVIEW
Published on 01 Oct 2024
Diagnosis and management of multiple primary lung cancer
doi 10.3389/fonc.2024.1392969
- 533 views
REVIEW
Published on 30 Aug 2024
Lung fibrosis in sarcoidosis. Is there a place for antifibrotics?
doi 10.3389/fphar.2024.1445923
- 1,772 views
ORIGINAL RESEARCH
Published on 08 Aug 2024
Long-term effects of mepolizumab in patients with severe eosinophilic asthma: a 6-year real-life experience
doi 10.3389/fphar.2024.1449220
- 1,114 views
POLICY AND PRACTICE REVIEWS
Published on 06 Aug 2024
Breaking down barriers to COPD management in primary care: applying the updated 2023 Canadian Thoracic Society guideline for pharmacotherapy
doi 10.3389/fmed.2024.1416163
- 1,241 views
ORIGINAL RESEARCH
Published on 08 Jul 2024
Camrelizumab combined with anlotinib as second-line therapy for metastatic or recurrent small cell lung cancer: a retrospective cohort study
doi 10.3389/fonc.2024.1391828
- 599 views
- 1 citation
Published in
Frontiers in Pharmacology
- Respiratory Pharmacology
- Inflammation Pharmacology
Participating Journals
Frontiers in Immunology
Inflammation PharmacologyOffline
- 5.7 impact factor
- 9.8 citescore
Impact
- 16kTopic views
- 10kArticle views
- 4,734Article downloads